PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAntithrombin iii human
Antithrombin iii human
Antithrombin iii human is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Thrombate
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Antithrombin iii (human)
Tradename
Proper name
Company
Number
Date
Products
Thrombate IiiAntithrombin III (Human)GrifolsA-103196 RX1991-12-30
1 products
Labels
FDA
EMA
Brand Name
Status
Last Update
thrombate iiiBiologic Licensing Application2010-01-10
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
B: Blood and blood forming organ drugs
B01: Antithrombotic agents
B01A: Antithrombotic agents
B01AB: Heparin group antithrombotic drugs
B01AB02: Antithrombin iii
HCPCS
No data
Clinical
Clinical Trials
4341 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C502851151195308
NeoplasmsD009369C80454083171219
LymphomaD008223C85.9265249117134
SyndromeD0135778132223678
Pancreatic neoplasmsD010190EFO_0003860C2517252811778
Hiv infectionsD015658EFO_0000764B20773711058
Covid-19D000086382U07.1593211656
Diabetes mellitusD003920EFO_0000400E08-E13462721852
Type 2 diabetes mellitusD003924EFO_0001360E11433251152
Heart failureD006333EFO_0003144I5055843050
Show 136 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD002289258210437225
Lung neoplasmsD008175C34.9020576249171
CarcinomaD002277C80.017367824138
Colorectal neoplasmsD01517913295742127
MelanomaD00854540581521122
Prostatic neoplasmsD011471C6110156130114
Ovarian neoplasmsD010051EFO_0003893C562127342499
LeukemiaD007938C951528471398
Multiple myelomaD009101C90.02235351298
Plasma cell neoplasmsD0542192030271284
Show 776 more
Indications Phases 1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cerebral palsyD002547G801515
ExerciseD015444EFO_00004831010
Neck painD019547M54.21010
Angle class iii malocclusionD008313M26.21388
ParalysisD01024377
Pressure ulcerD003668L8977
PrognathismD01137877
DeathD003643PATO_000142266
AgingD000375GO_0007568R41.8166
Sedentary behaviorD05718566
Show 569 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAntithrombin iii human
INNantithrombin iii
Description
Antithrombin iii human is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2108574
ChEBI ID
PubChem CID
DrugBank
UNII IDT0LTO7L82X (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 47,113 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
142 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use